Elijah Paintsil MBChB, MD
Associate Professor of Pediatrics (Infectious Disease), of Epidemiology (Microbial Diseases) and of Pharmacology; Associate Professor of Pharmacology
Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology | Biochemistry, Biophysics and Structural Biology
Yale Medical Group
Office of International Medical Student Education
Office of Student ResearchInfectious DiseasesWomen & Child HealthCancer Center, Yale: Molecular VirologyPharmacology | School of Public Health: Center for Interdisciplinary Research on AIDSAIDS Care Program | Pediatrics: Pediatric Infectious Diseases; Pediatric Specialty Center
HIV translational research; Cellular pharmacology of HIV-RT inhibitors in relation to clinical toxicities; Fitness and evolution of HIV drug resistant mutants; Molecular epidemiology and dynamics of HIV/HCV transmission more...
- M.B.Ch.B., Ghana Medical School, 1992
- Yang G, Paintsil E, Dutschman GE, Grill SP, Wang CJ, Wang J, Tanaka H, Hamasaki T, Baba M, Cheng YC. Impact of Novel HIV-1 Reverse Transcriptase Mutations, P119S and T165A on 4'-ethynylthymidine Analog Resistance Profile. Antimicrob Agents Chemother. 2009 Aug 24
- Elijah Paintsil, Susan P. Grill, Ginger E. Dutschman, and Yung-Chi Cheng. 2009. Comparative Study of the Persistence of Anti-HIV Activity of Deoxynucleoside HIV Reverse Transcriptase Inhibitors after Removal from Culture. AIDS Res Ther. 2009 Apr 22;6:5.
- Elijah Paintsil, Sergei Verevochkin, Elena Dukhovlinova, Linda Niccolai, Russell Barbour, Edward White, Olga Toussova, Louis Alexander, Andrei Kozlov, and Robert Heimer . Hepatitis C Virus infection among drug injectors in St. Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction. 2009 Aug 27